{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:19:08Z","timestamp":1775870348160,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["PIE-201420E109"],"award-info":[{"award-number":["PIE-201420E109"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00703"],"award-info":[{"award-number":["PI14\/00703"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RTC-2015-3786-1, RTC-2015-3846-1"],"award-info":[{"award-number":["RTC-2015-3786-1, RTC-2015-3846-1"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00077","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T08:52:11Z","timestamp":1517215931000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["92R Monoclonal Antibody Inhibits Human CCR9+ Leukemia Cells Growth in NSG Mice Xenografts"],"prefix":"10.3389","volume":"9","author":[{"given":"Beatriz","family":"Somovilla-Crespo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Mart\u00edn Monz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Corraliza-Gorj\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Garcia-Sanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1034\/j.1600-065X.2003.00075.x","article-title":"Lymphoid organ development and cell migration","volume":"195","author":"Cyster","year":"2003","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1182\/blood.V97.4.850","article-title":"Expression of CCR9 beta-chemokine receptor is modulated in thymocyte differentiation and is selectively maintained in CD8(+) T cells from secondary lymphoid organs","volume":"97","author":"Carramolino","year":"2001","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.4049\/jimmunol.162.10.5671","article-title":"Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK","volume":"162","author":"Zaballos","year":"1999","journal-title":"J Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/1521-4141(200001)30:1<262:AID-IMMU262>3.0.CO;2-0","article-title":"The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9","volume":"30","author":"Wurbel","year":"2000","journal-title":"Eur J Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.V94.7.2533.419k37_2533_2536","article-title":"TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6\/CCR9 as a specific receptor","volume":"94","author":"Youn","year":"1999","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1084\/jem.192.5.761","article-title":"Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity","volume":"192","author":"Kunkel","year":"2000","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.190.9.1241","article-title":"Human G protein-coupled receptor GPR-9-6\/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis","volume":"190","author":"Zabel","year":"1999","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1073\/pnas.0609180104","article-title":"CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine","volume":"104","author":"Wendland","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.V98.9.2626","article-title":"Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes","volume":"98","author":"Wurbel","year":"2001","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1074-7613(00)80531-2","article-title":"TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development","volume":"7","author":"Vicari","year":"1997","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10585-007-9097-3","article-title":"Organ selectivity in metastasis: regulation by chemokines and their receptors","volume":"25","author":"Ben-Baruch","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/1078-0432.CCR-07-2025","article-title":"Activation of CCR9\/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine","volume":"14","author":"Amersi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.0022-202X.2004.22315.x","article-title":"Functional CCR9 expression is associated with small intestinal metastasis","volume":"122","author":"Letsch","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1158\/1078-0432.CCR-07-2235","article-title":"CCR9 homes metastatic melanoma cells to the small bowel","volume":"14","author":"Richmond","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B17","first-page":"6469","article-title":"Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia","volume":"63","author":"Qiuping","year":"2003","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ncponc1174","article-title":"The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine","volume":"5","author":"van den Oord","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/path.3015","article-title":"Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia","volume":"226","author":"Mirandola","year":"2012","journal-title":"J Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3892\/ijo.2011.953","article-title":"CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion","volume":"38","author":"Johnson-Holiday","year":"2011","journal-title":"Int J Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1158\/1078-0432.CCR-04-0266","article-title":"Expression and functional role of CCR9 in prostate cancer cell migration and invasion","volume":"10","author":"Singh","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nri3049","article-title":"Homeostatic chemokine receptors and organ-specific metastasis","volume":"11","author":"Zlotnik","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-016-0236-7","article-title":"CCR9 in cancer: oncogenic role and therapeutic targeting","volume":"9","author":"Tu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1757-2215-3-15","article-title":"CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion","volume":"3","author":"Johnson","year":"2010","journal-title":"J Ovarian Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/ijc.25219","article-title":"CCR9 mediates PI3K\/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide","volume":"127","author":"Sharma","year":"2010","journal-title":"Int J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/dna.2015.3104","article-title":"CCL25\/CCR9 signal promotes migration and invasion in hepatocellular and breast cancer cell lines","volume":"35","author":"Zhang","year":"2016","journal-title":"DNA Cell Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.6084\/m9.figshare.2058642.v1","article-title":"Analysis of chemokine receptor gene expression in esophageal cancer cells compared with breast cancer with insights into metastasis","volume":"44","author":"Mishan","year":"2015","journal-title":"Iran J Public Health"},{"key":"B28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12032-015-0531-0","article-title":"CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K\/Akt pathway","volume":"32","author":"Li","year":"2015","journal-title":"Med Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12307-013-0130-6","article-title":"Paracrine activation of chemokine receptor CCR9 enhances the invasiveness of pancreatic cancer cells","volume":"6","author":"Heinrich","year":"2013","journal-title":"Cancer Microenviron"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10170","DOI":"10.18632\/oncotarget.2526","article-title":"CCR9\/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis","volume":"5","author":"Gupta","year":"2014","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1158\/0008-5472.CAN-04-0641","article-title":"CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation","volume":"64","author":"Qiuping","year":"2004","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2015.00012","article-title":"Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges","volume":"6","author":"Vela","year":"2015","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.leukres.2011.01.015","article-title":"Specific killing of CCR9 high-expressing acute T lymphocytic leukemia cells by CCL25 fused with PE38 toxin","volume":"35","author":"Hu","year":"2011","journal-title":"Leuk Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.4161\/mabs.29063","article-title":"Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts","volume":"6","author":"Chamorro","year":"2014","journal-title":"MAbs"},{"key":"B35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/1-59259-435-2:243","article-title":"Generation of monoclonal antibodies against chemokine receptors","volume":"239","author":"Kremer","year":"2004","journal-title":"Methods Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1006\/jmbi.1999.2731","article-title":"Domain architecture of the bacteriophage phi29 connector protein","volume":"288","author":"Valle","year":"1999","journal-title":"J Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0076-6879(00)23372-7","article-title":"Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with BIACORE","volume":"323","author":"Myszka","year":"2000","journal-title":"Methods Enzymol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/bjh.14874","article-title":"Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study","volume":"179","author":"Zwaan","year":"2017","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2017.07.019","article-title":"Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia","volume":"405","author":"Moharram","year":"2017","journal-title":"Cancer Lett"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.molonc.2015.04.012","article-title":"CCR9-mediated signaling through beta-catenin and identification of a novel CCR9 antagonist","volume":"9","author":"Lee","year":"2015","journal-title":"Mol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.4049\/jimmunol.164.3.1293","article-title":"CCR9A and CCR9B: two receptors for the chemokine CCL25\/TECK\/Ck beta-15 that differ in their sensitivities to ligand","volume":"164","author":"Yu","year":"2000","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1074\/jbc.M309689200","article-title":"Analysis of post-translational CCR8 modifications and their influence on receptor activity","volume":"279","author":"Gutierrez","year":"2004","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/bph.12455","article-title":"The structural role of receptor tyrosine sulfation in chemokine recognition","volume":"171","author":"Ludeman","year":"2014","journal-title":"Br J Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.str.2014.08.023","article-title":"Structural basis of receptor sulfotyrosine recognition by a CC chemokine: the N-terminal region of CCR3 bound to CCL11\/eotaxin-1","volume":"22","author":"Millard","year":"2014","journal-title":"Structure"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:38:41Z","timestamp":1693507121000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2018.00077"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00077","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"article-number":"77"}}